论文部分内容阅读
肝癌术后复发与转移是进一步提高肝癌疗效的瓶颈,在缺乏公认的预防复发转移手段的前提下,复发性肝癌的早诊早治显得尤为重要。应综合考虑肿瘤的生物学特征、肝脏储备功能、残余肝体积以及病人的全身情况等因素,选择再切除、挽救性肝移植、局部消融、经肝动脉栓塞化疗、放疗和系统治疗等方法,对复发性肝癌进行多学科综合治疗。在缺少前瞻性随机对照临床研究结果的情况下,Meta分析是评价不同治疗策略疗效的重要依据。
Postoperative recurrence and metastasis of liver cancer is the bottleneck to further improve the efficacy of liver cancer. In the absence of recognized means to prevent recurrence and metastasis, early diagnosis and treatment of recurrent liver cancer is particularly important. The biological characteristics of the tumor, the function of the liver reserve, the residual liver volume and the general condition of the patient should be considered in combination with the methods of resection, salvage liver transplantation, local ablation, transcatheter arterial chemoembolization, radiotherapy and systemic treatment Recurrent liver cancer for multidisciplinary comprehensive treatment. In the absence of prospective randomized clinical trial results, Meta-analysis is an important basis for evaluating the efficacy of different treatment strategies.